Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Mesothelioma × UV1 vaccine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lung Neoplasms 1

Interventions

pembrolizumab 6 Nivolumab 3 Cyclophosphamide 3 fludarabine 2 Ipilimumab 2 tislelizumab 1 sargramostim 1 obinutuzumab 1 naptumomab estafenatox 1 durvalumab 1 UV1 vaccine 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Cisplatin 1 Cerebral Decortication 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04300244 2024-02-29

NIPU

Oslo University Hospital

Phase 2 Active not recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡